Division Leadership

Human Biology Division

Division Leadership

Director, Eric Holland, MD, PhD

Eric Holland is an internationally renowned neurosurgeon and brain cancer researcher, who was selected as a Senior Vice President at Fred Hutch and Director of the Human Biology Division in 2013. He is also Director of the Seattle Translational Tumor Research program —a new multi-institutional initiative targeting solid tumors and spanning all divisions and disciplines. In addition, Eric Holland is Director of the Nancy and Buster Alvord Brain Tumor Center at the University of Washington Medicine and a professor in the Department of Neurological Surgery. Eric Holland is committed to keeping the scientific focus of the division diverse while growing solid tumor research at the Center.

Dr. Holland has spent his career working across disciplines to address the molecular basis of brain tumors and develop new treatment approaches. His research focuses on developing mouse models of brain cancer that mimic how the disease behaves in patients. As a practicing neurosurgeon with research in molecular biology and genetics, Dr. Holland is at the forefront of translating laboratory advances into advanced molecular therapeutics – expertise that will be instrumental in catalyzing efforts to build strength in clinical molecular diagnostics and precision oncology.

Associate Director, Denise Galloway, PhD

Denise Galloway is the associate director of the Human Biology Division and a member of the Public Health Sciences Division. She is also scientific director of the Pathogen-Associated Malignancies Integrated Research Center, a Fred Hutch 40th Anniversary Endowed Chair, and a professor of microbiology at the University of Washington School of Medicine. Galloway has a longstanding history with the Human Biology Division at Fred Hutch and is committed to continuing to support its scientists as associate director.

Early in her career, she became fascinated by the idea that a virus could lead to cancer by sparking changes within cells. This idea led her to study the human papillomavirus (HPV) and to make breakthrough contributions that paved the way to a vaccine that prevents HPV and averts tens of thousands of cervical cancer cases of cervical cancer, as well as other cancers, each year.

The Galloway Lab focuses on the role that small DNA viruses play in cancer, not only of high risk HPVs in anogenital cancers, but genus beta HPVs in squamous cell skin cancers, and the Merkel cell polyomavirus (MCPyV) in Merkel cell carcinomas. Her team has taken a broad-based approach that includes mechanistic studies into how the viral oncoproteins contribute to neoplasia, and molecular epidemiologic studies into the natural history of viral infections and risk factors that are associated with the development of these cancers.

Associate Director, Adam Geballe, MD

Adam Geballe is transitioning into the role of associate director of the Human Biology Division and is also a member in the Clinical Research Division. He was also named a fellow of the American Association for the Advancement of Science (AAAS).

Geballe, who arrived at the Hutch 30 years ago, studies how large DNA viruses like cytomegalovirus interact with target cells and the strategies each side continually evolves to evade or combat the other. He also consults on infectious disease cases at Seattle Cancer Care Alliance, Fred Hutch’s clinical care partner.

Senior Operations Director, Angie Schroeder, MBA

Image: Angie Schroeder

Angie Schroeder is the Senior Operations Director for Human Biology. She oversees day-to-day and long-range strategic planning and all operational, financial and human resources for the Division.